[Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia].
作者信息
Jonas U, Melchior H, Rübben H
出版信息
Urologe A. 1998 Jan;37(1):110-1.
PMID:9540196
Abstract
摘要
相似文献
1
2
[Transurethral high energy microwave (thermo-) therapy of benign prostatic hyperplasia].经尿道高能微波（热）治疗良性前列腺增生症
Urologe A. 1998 Jan;37(1):111-2.
3
[GreenLight laser therapy for benign prostatic hyperplasia: dilemma of reimbursement in the DRG system].[绿激光治疗良性前列腺增生症：疾病诊断相关分组（DRG）系统中的医保报销困境]
Urologe A. 2009 Feb;48(2):177-82. doi: 10.1007/s00120-008-1885-0.
4
A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.一项关于前列腺光选择性汽化术与其他微创治疗方法及经尿道前列腺切除术治疗良性前列腺增生的临床结果和成本分析。
J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064.
5
[Alternative and innovative treatment methods. Who pays when federal insurance doesn't pay?].
MMW Fortschr Med. 2002 Apr 25;144(17):46.
6
Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis.钬激光剜除术与开放性前列腺切除术治疗良性前列腺增生症的住院费用分析
Urology. 2006 Aug;68(2):302-6. doi: 10.1016/j.urology.2006.02.007.
7
[What reimbursement can ambulatory surgery physicians expect?].
Chirurg. 1997 Jun;68(6):Suppl 171-4.
8
[Economic evaluation: what needs to be done in fee reduction or regress?].[经济评估：在费用降低或回归中需要做什么？]
MMW Fortschr Med. 2006 Nov 16;148(46):56-8.
9
[Complementary medicine as political process. Swiss public opinion on the "Future with Complementary Medicine"].[作为政治进程的补充医学。瑞士公众对“补充医学的未来”的看法]
Forsch Komplementmed. 2009 Apr;16(2):76-8. doi: 10.1159/000203073. Epub 2009 Mar 3.
10
[Requirements and needs--health between solidarity and commerce].[要求与需求——团结与商业之间的健康]
Forsch Komplementmed. 2009 Apr;16(2):72-4. doi: 10.1159/000209149. Epub 2009 Apr 2.
Zotero 插件